Intellikine
Pioneering novel therapies by creating exceptional teams and powerful platforms for rapid discovery in the PI3K/Akt/mTOR pathway.
General Information
BounceWatch is an independent company data service, not affiliated with Intellikine. To contact Intellikine, visit intellikine.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Intellikine compare?
A PDF of Intellikine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Intellikine soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Intellikine
Business keywords: pharmaceuticals, drug discovery, medical innovation, small molecule therapies, PI3K/Akt/mTOR pathway, kinase inhibitors, team building, discovery platform, startup, investment potential
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $4.00M | - |
|
31 Oct 2011 |
| Series B | $51.00M | 6 |
|
22 Jul 2009 |
| Series B | $30.00M | 1 |
|
01 Jun 2007 |
Intellikine Alternatives & Competitors
View All Alternatives
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...
Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of nov...
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kinase inhibit...
FAQ About Intellikine
Source: BounceWatch company record for Intellikine, https://bouncewatch.com/company/intellikine, updated 26 December 2024. When citing, please name BounceWatch and link this page.
